Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Lung Non-Small Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00406276
What this trial is testing

Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Emory University 28
Testing effectiveness (Phase 2)Ended earlyNCT02119650
What this trial is testing

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation 76
Testing effectiveness (Phase 2)Study completedNCT00407550
What this trial is testing

Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 19
Testing effectiveness (Phase 2)Study completedNCT01557959
What this trial is testing

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more
Wake Forest University Health Sciences 45
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Not applicableStudy completedNCT00450567
What this trial is testing

Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT00004201
What this trial is testing

Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Herbert Irving Comprehensive Cancer Center
Not applicableActive Not RecruitingNCT02178163
What this trial is testing

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute 619
Testing effectiveness (Phase 2)Ended earlyNCT00955305
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Large Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 175
Testing effectiveness (Phase 2)Study completedNCT00278070
What this trial is testing

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Who this might be right for
Breast CancerNon Small Cell Lung CancerProstate Cancer
Hellenic Cooperative Oncology Group
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Large-scale testing (Phase 3)Study completedNCT00805194
What this trial is testing

LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,314
Large-scale testing (Phase 3)Study completedNCT03196986
What this trial is testing

Mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Beijing Mabworks Biotech Co., Ltd. 517
Not applicableUnknownNCT04492969
What this trial is testing

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Fudan University 320
Testing effectiveness (Phase 2)Ended earlyNCT05117242
What this trial is testing

Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Genmab 125
Testing effectiveness (Phase 2)Ended earlyNCT02963610
What this trial is testing

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Who this might be right for
Relapsed or Refractory Solid TumorsNonsmall Cell Lung Cancer
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT02823990
What this trial is testing

TG4010 and Nivolumab in Patients With Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage II Non-Small Cell Lung Cancer+3 more
Megan Daly, MD 13
Testing effectiveness (Phase 2)Study completedNCT02655913
What this trial is testing

Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+2 more
Clifford Hospital, Guangzhou, China 97
Testing effectiveness (Phase 2)Study completedNCT00219297
What this trial is testing

Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasisNon-small Cell Lung Cancer
Novartis Pharmaceuticals 50
Next Page